Anticoagulation for continuous renal replacement therapy in critically ill patients

Authors

  • L. Fernández-Lorente Servicio de Nefrología. CHN.

DOI:

https://doi.org/10.23938/ASSN.0226

Downloads

Download data is not yet available.

References

SANZ M, HIDALGO F, GARCÍA-FERNÁNDEZ N. Supervivencia de circuitos de técnicas de depuración extrarrenal continua en pacientes críticos con o sin anticoagulación convencional: estudio observacional prospectivo. An Sist Sanit Navar 2017; 40: 77-84.

TOLWANI A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 2012; 367: 2505-2514.

HEUNG M, YESSAYAN L. Renal replacement therapy in acute kidney injury: controversies and consensus. Crit Care Clin 2017; 33: 365-378.

KLINGELE M, STADLER T, FLISER D, SPEER T, GROESDONK HV, RADDATZ A. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Critical Care 2017; 21:294. doi: 10.1186/s13054-017-1870-3.

WU MY, HSU YH, BAI CH, LIN YF, WU CH, TAM KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012; 59: 810-818.

SCHNEIDER AG, JOURNOIS D, RIMMELÉ T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care 2017; 21:281. doi: 10.1186/s13054-017-1880-1.

KDIGO WORK GROUP. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2. doi:10.1038/kisup.2012.6

Published

2018-04-30

How to Cite

1.
Fernández-Lorente L. Anticoagulation for continuous renal replacement therapy in critically ill patients. An Sist Sanit Navar [Internet]. 2018 Apr. 30 [cited 2026 Feb. 10];41(1):131-3. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/63052

Issue

Section

Letters to the Editor